Over the past few years, obesity treatment has evolved faster than almost any other area of medicine
Despite the lack of consistent clinical and epidemiological evidence, the potential link between GLP-1 receptor agonists and thyroid cancer has received considerable attention
BMI is one of the most important factors healthcare providers consider, but it is not the only consideration
The placebo group showed a 3 percent hypersensitivity rate, suggesting that some increase does occur with active medication, though the absolute numbers remain modest
If eating enough feels difficult due to reduced appetite from Retatrutide, consider adding a protein shake to your routine
One honesty note: my own microdose was tirzepatide (Mounjaro), not semaglutide